Walleye Trading’s Beam Therapeutics BEAM Stock Holding History

Walleye Trading’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$42.9K	Sell	1,800 -6,000	-77%	-$166K	﹤0.01%	3720
2025 Q4	$216K	Sell	7,800 -24,000	-75%	-$612K	﹤0.01%	3345
2025 Q3	$772K	Buy	31,800 +23,700	+293%	+$471K	﹤0.01%	2443
2025 Q2	$138K	Buy	+8,100	New	+$141K	﹤0.01%	3445
2024 Q1	–	Sell	-27,400	Closed	-$746K	–	4764
2023 Q4	$746K	Buy	27,400 +4,100	+18%	+$102K	﹤0.01%	2736
2023 Q3	$560K	Sell	23,300 -2,300	-9%	-$61.7K	﹤0.01%	2861
2023 Q2	$817K	Buy	25,600 +8,300	+48%	+$269K	﹤0.01%	2371
2023 Q1	$530K	Sell	17,300 -15,800	-48%	-$624K	﹤0.01%	2748
2022 Q4	$1.29M	Buy	33,100 +1,100	+3%	+$49.3K	﹤0.01%	2020
2022 Q3	$1.52M	Buy	32,000 +23,200	+264%	+$1.32M	﹤0.01%	1918
2022 Q2	$341K	Buy	8,800 +4,900	+126%	+$195K	﹤0.01%	3291
2022 Q1	$223K	Buy	+3,900	New	+$256K	﹤0.01%	3696

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Walleye Trading's BEAM Position: Q1 2026 in Review

Walleye Trading opened a new position in Beam Therapeutics (BEAM) in Q1 2026: 183 shares worth $4.36K. The stake represents ﹤0.01% of the portfolio and ranks #3983 among its holdings. This is a return to the name: Walleye Trading previously reported a position in BEAM as recently as Q2 2025.

Walleye Trading first reported a position in BEAM in Q2 2022 and has held it in 6 quarters since. The position peaked at $508K in Q4 2022. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

Walleye Trading held 183 shares of Beam Therapeutics worth $4.36K as of Q1 2026.
Beam Therapeutics was a new Walleye Trading position in Q1 2026.
Beam Therapeutics made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #3983 holding.
Walleye Trading first reported a position in Beam Therapeutics in Q2 2022 and has held it in 6 quarters since.
Walleye Trading's Beam Therapeutics position peaked at $508K in Q4 2022.
251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.